Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is well-positioned for future growth due to its integrated software and payments platform addressing healthcare delivery challenges, and its diverse customer base including ambulatory practices, health systems, and life sciences companies. This has been reflected in the company's strong adjusted EBITDA margin, expected to reach 28% by the end of FY27, and potential for upside risks to the current price target and rating. Furthermore, the company's recent acquisition of AccessOne may lead to additional growth opportunities, although it has seen a decline in revenue and net income in recent years. While there may be some challenges in integrating and scaling this business, Phreesia's track record of successful acquisitions suggests a positive outlook for the company's long-term growth prospects.

Bears say

Phreesia is facing headwinds in its Network Solutions segment due to weak pharmaceutical demand, and also has concerns about its ability to cross-sell into large health systems that use Epic as their primary EHR. Additionally, the healthcare industry is rapidly evolving and the market for technology-enabled services is immature and unproven, which could limit Phreesia's growth potential. The company also faces competition from both smaller, point solution vendors and larger, well-capitalized players, and may struggle to retain clients due to provider consolidation. Overall, there are significant fundamental risks for Phreesia that could hinder its long-term success.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.